HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Changes in composition of cardiac myosin light chains in dilated cardiomyopathy: effect on functional properties].

Abstract
A reduction (by 16-24%) in the amount of myosin regulatory light chains (LC2) in all heart sections of patients with dilated cardiomyopathy was found. The appearance of atrial essential light chains in ventricular myosin (up to 23%) not typical for this heart section in norm was also revealed. The decrease in LC2 content leads to a considerable inhibition of actin-activated ATPase activity and a loss of Ca2+ sensitivity of reconstructed filaments of myosin isolated from atria and ventricles of patients with dilated cardiomyopathy. The hybridization of myosin molecules from heavy chains of pathological human left ventricular myosin and light chains of pig left ventricular myosin leads to an increase in actin-activated ATPase activity of myosin and its Ca2+ sensitivity to the control level. The data suggest strongly the contribution of LC2-deficit to the distortion of functional properties of myosin in dilated cardiomyopathy. In contrast, the appearance of atrial LC1 in ventricle in dilated cardiomyopathy is a factor improving these properties.
AuthorsIa N Khalina, S N Udal'tsov, Z A Podlubnaia
JournalBiofizika (Biofizika) 2002 Mar-Apr Vol. 47 Issue 2 Pg. 361-6 ISSN: 0006-3029 [Print] Russia (Federation)
Vernacular TitleIzmenenie sostava legkih tsepeĭ serdechnogo miozina pri dilatatsionnoĭ kardiomiopatii: vliianie na funktsional'nye svoĭstva.
PMID11969177 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Actins
  • Myosin Light Chains
  • Adenosine Triphosphatases
  • Calcium
Topics
  • Actins (metabolism)
  • Adenosine Triphosphatases (metabolism)
  • Animals
  • Calcium (metabolism)
  • Cardiomyopathy, Dilated (metabolism)
  • Electrophoresis, Polyacrylamide Gel
  • Humans
  • Myocardium (chemistry, metabolism)
  • Myosin Light Chains (chemistry, metabolism)
  • Swine

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: